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ABSTRACT
Objective Suboptimal adenoma detection rate (ADR)
at colonoscopy is associated with increased risk of
interval colorectal cancer. It is uncertain how ADR might
be improved. We compared the effect of leadership
training versus feedback only on colonoscopy quality in a
countrywide randomised trial.
Design 40 colonoscopy screening centres with
suboptimal performance in the Polish screening programme
(centre leader ADR ≤25% during preintervention phase
January to December 2011) were randomised to either a
Train-Colonoscopy-Leaders (TCLs) programme (assessment,
hands-on training, post-training feedback) or feedback only
(individual quality measures). Colonoscopies performed
June to December 2012 (early postintervention) and
January to December 2013 (late postintervention) were
used to calculate changes in quality measures. Primary
outcome was change in leaders’ ADR. Mixed effect models
using ORs and 95% CIs were computed.
Results The study included 24 582 colonoscopies
performed by 38 leaders and 56 617 colonoscopies
performed by 138 endoscopists at the participating centres.
The absolute difference between the TCL and feedback
groups in mean ADR improvement of leaders was 7.1%
and 4.2% in early and late postintervention phases,
respectively. The TCL group had larger improvement in ADR
in early (OR 1.61; 95% CI 1.29 to 2.01; p<0.001) and
late (OR 1.35; 95% CI 1.10 to 1.66; p=0.004)
postintervention phases. In the late postintervention phase,
the absolute difference between the TCL and feedback
groups in mean ADR improvement of entire centres was
3.9% (OR 1.25; 95% CI 1.04 to 1.50; p=0.017).
Conclusions Teaching centre leaders in colonoscopy
training improved important quality measures in screening
colonoscopy.
Trial registration number NCT01667198.
INTRODUCTION
During recent years, several studies have shown
that important patient outcome measures such as
interval cancer rates after screening colonoscopy or
mortality after cancer surgery are related to quality
of hospitals and individual physicians.1–3 However,
there is a lack of high quality studies investigating
the effect of quality improvement interventions on
patient outcome measures.
Screening colonoscopy is widely used for preven-
tion and early detection of colorectal cancer
(CRC).4 High quality colonoscopy achieving
accurate detection and removal of adenomas is con-
sidered the key to screening efﬁcacy.5–7 Professional
societies recommend that endoscopists measure
quality indicators such as adenoma detection rate
(ADR), caecal intubation rate (CIR) and colono-
scope withdrawal time.6 7 We have previously
shown that an individual endoscopist’s ADR is an
independent predictor for interval cancer after
screening colonoscopy.1 Recently, a large US study
conﬁrmed this association and expanded it to
include CRC death.3 Thus, adenoma detection is of
paramount importance for the success of CRC
screening programmes. However, it has been uncer-
tain how to improve ADR in endoscopists with
suboptimal performance.
Open Access
Scan to access more
free content
Signiﬁcance of this study
What is already known on this subject?
▸ Suboptimal adenoma detection at colonoscopy
is associated with increased risk of interval
colorectal cancer and colorectal cancer death.
▸ Interventions targeting endoscopist
performance have been generally ineffective for
improving adenoma detection rates.
▸ One small study performed at single academic
institution showed adenoma detection rate
improvement with training.
What are the new ﬁndings?
▸ Dedicated Train-Colonoscopy-Leaders course
signiﬁcantly improved adenoma detection rate,
proximal adenoma detection rate and
non-polypoid lesion detection rate in screening
colonoscopy.
▸ The training of screening centre leaders in
teaching high quality colonoscopy changed
their own practice and had also signiﬁcant
effect on overall centre performance.
▸ The Train-Colonoscopy-Leaders course had
sustained effect on colonoscopy performance
over 1.5 years.
How might it impact on clinical practice in
the foreseeable future?
▸ Developed training curriculum may help to
improve adenoma detection rate and
non-polypoid lesion detection rate at
colonoscopy.
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Simple interventions, such as involvement of a trainee or
video recording of the colonoscopy,8–11 or an institutional
policy to keep colonoscope withdrawal time above the recom-
mended limits12 13 has not shown signiﬁcant improvements of
ADR.14 It has been proposed that improving ADR requires a
multifaceted change15 16 in the knowledge, skills and motivation
of endoscopists. Audit and feedback of screening colonoscopy
quality indicators have proven to be moderately effective in
improving adenoma detection for some but not all endosco-
pists,17 18 and an educational intervention improved adenoma
detection of gastroenterologists at one academic institution.19
Multicentre, comparative studies on the effect of quality
improvement strategies to increase ADR are lacking.
The present large-scale randomised trial investigates the effect
of a hands-on training course for leading colonoscopists at
screening centres to improve their adenoma ﬁnding skills and
overall screening centre performance compared with a simple
audit and feedback.
METHODS
Study design
This was a multicentre, randomised (1:1 ratio), single-blind,
parallel-group study performed in 40 centres of the National
Colorectal Cancer Screening Programme (NCRCSP) in Poland.
The NCRCSP is a colonoscopy-based programme involving
asymptomatic subjects 40–66 years of age.20 21 Each participat-
ing centre has one dedicated leading colonoscopist who is
responsible for coordination and supervision of the programme
locally (screening centre leader; usually formal head of the
endoscopy unit who underwent training in administration of the
screening centre when entering the NCRCSP). We compared
the effect of two educational interventions on ADR of these
screening centre leaders and all endoscopists working at their
centres.
The study was conducted in four phases: (i) preintervention
phase, (ii) intervention phase, (iii) early postintervention phase
and (iv) late postintervention phase. In the preintervention
phase (1 January 2011 to 31 December 2011), colonoscopy
quality indicators were extracted from the NCRCSP database.
Centre leaders were unaware of the study during this phase. At
the start of the intervention phase, screening centre leaders were
randomly assigned to either a designated educational interven-
tion (‘Train-Colonoscopy-Leaders course’ (TCL)) or to routine
audit and feedback. Both interventions started on 1 June 2012
and the TCL phase was completed by 30 August 2012. Quality
indicators were measured in the early postintervention phase (1
June 2012 to 31 December 2012; leaders were aware of being
closely monitored) and in the late postintervention phase (1
January 2013 to 31 December 2013; leaders were unaware of
being closely monitored) using the same method.
The study was approved by the Research Ethical Committee
of the Maria Sklodowska-Curie Memorial Cancer Centre and
Institute of Oncology, Warsaw, Poland (#17/2012). Written
informed consent was obtained from all screening participants
entering the NCRCSP and all screening centre leaders. The
study was registered with ClinicalTrials.gov, NCT01667198.
Endpoints and deﬁnitions
Study endpoints were differences between preintervention and
postintervention colonoscopy quality indicators in the two arms
using all colonoscopies recorded in the NCRCSP database. The
screening colonoscopy procedures have been described previ-
ously.20 Findings at screening colonoscopy were categorised on
the basis of the most advanced lesion identiﬁed.20 Polyps that
were not removed or retrieved were categorised as non-
neoplastic and not taken into account when calculating ADR.
The primary study endpoint was the change in screening
centre leaders’ ADR from preintervention to early postinterven-
tion phase. ADR was deﬁned as the proportion of screened sub-
jects in whom at least one adenoma was identiﬁed.7 Predeﬁned
secondary endpoints for the early postintervention phase were
proximal ADR (deﬁned as ADRs proximal to the splenic
ﬂexure), non-polypoid lesion detection rate and CIR, all of
which were evaluated for both screening centre leaders and for
the centres. All these endpoints were subsequently measured for
the late postintervention phase compared with the preinterven-
tion phase. CIR was deﬁned as the proportion of colonoscopies
in which the endoscope tip reached proximal to the ileocaecal
valve and the entire caecum was visualised.7 Non-polypoid
lesions were deﬁned as lesions 5 mm or larger which were
depressed, completely ﬂat or elevated less than 2.5 mm.22
Study colonoscopists
All screening centre leaders who performed at least 30
NCRCSP screening colonoscopies in 2011 and achieved an
ADR lower than 25% were eligible for the study (40 out of 93
centres in the NCRCSP) unless they discontinued participating
in the NCRCSP in 2012.
Randomisation and masking
In May 2012, eligible screening centre leaders were randomly
assigned in a 1:1 ratio to the TCL group or the feedback group.
Randomisation lists were computer-generated and stratiﬁed by
screening centre leader baseline ADR category (<11%, 11%–
14.9%, 15%–19.9%, 20.0%–24.9%).1 Participating screening
centre leaders were informed that they were participating in a
trial testing two different training programmes dedicated for
trainers but were not informed about trial aims and endpoints.
All other colonoscopists were not informed about the study but
were aware of being monitored as a routine part of the
NCRCSP. In the year 2013 (late postintervention phase), all
colonoscopists (including screening centre leaders) were aware
only of being monitored as a routine part of the NCRCSP.
Feedback group
Screening centre leaders randomised to the feedback group
received (by email and surface mail) feedback on their individual
preintervention screening colonoscopy quality indicators along
with aggregated results for the entire screening centre. The indi-
vidual results were presented in a table to enable comparison
with anonymised results of all endoscopists who performed at
least 30 colonoscopies within the NCRCSP (see online supple-
mentary appendix 1). In addition, a link to a webpage contain-
ing data on individual and overall colonoscopy quality
indicators from the last 4 years of the NCRCSP was provided.
The email feedback was provided also after early postinterven-
tion phase.
TCLs group
Screening centre leaders randomised to the TCL group were
invited to participate in a TCL course consisting of three
phases: (i) pretraining assessment, (ii) hands-on training and (iii)
post-training evaluation and feedback (see online supplementary
appendix 2). The underlying hypothesis of the training interven-
tion was to train the leaders on how to teach high quality colon-
oscopy and thereby to facilitate self-development and
disseminate high standards of care.
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The pretraining assessment phase involved a 2-h visit held in
June and July 2012 at each screening centre. It used an environ-
mental assessment checklist to ﬁnd reasons for suboptimal per-
formance. After the pretraining visit, local endoscopy nurses
observed 10 consecutive colonoscopies performed by the
screening centre leader to assess patient discomfort (using a
100 mm visual analogue scale) and withdrawal technique.23
Local endoscopy nurses were trained to assess withdrawal tech-
nique and discomfort by the study team. Prior to starting the
hands-on training phase, the TCL trainers were subject to a
2-day intensive training course by UK trainers ( JA, RV) provid-
ing them with techniques used in skills improvement, training
the trainer and leadership training programmes developed in the
UK. During these 2 days, the focus was on using techniques
known to change professional practice.24 The hands-on training
phase consisted of two half-a-day courses at the NCRCSP
coordinating centre. The hands-on training course included at
least one session for each participating screening centre leader
playing the role of a trainee (performing colonoscopy) and at
least one as a trainer (supervising colonoscopy), observed by the
other course participants (by video streaming). The TCL trainers
from the Institute of Oncology facilitated discussion on the
training episode among all participants. The schedule of each
course was modiﬁed to address issues identiﬁed in the pretrain-
ing assessment. Six to seven screening colonoscopy leaders were
trained during each training session (held between July and
August 2012).
The post-training evaluation encompassed evaluation of the
screening centre leaders’ colonoscopy performance (extracted
from the database) during the ﬁrst 30 procedures following the
hands-on training course, and a further nurse assessment of 10
consecutive colonoscopies identical to that done in the pretrain-
ing phase. Finally, all leaders in the TCL group received feed-
back on individual performance along with aggregated results
for the entire screening centre and access to the same webpage
as leaders in the control group. The email feedback was pro-
vided also after early postintervention phase. According to
protocol of the study, we had not planned to assess whether
leaders extended training to other colleagues within the screen-
ing centre. Upon reviewers’ request, we have performed a brief
telephone survey among leaders asking whether they have
extended training to their colleagues.
Power estimates and statistical analyses
We considered an absolute ADR improvement of 3% in the screen-
ing centre leaders randomised to the TCL group compared with
1.5% in those randomised to the feedback group17 as clinically
meaningful to detect. A sample size of 34 screening centre leaders
provided 80% power to detect a mean difference in ADR improve-
ment of 1.5% with an estimated SD of 1.5% and a two-sided sig-
niﬁcance level (α) of 0.05. We planned to include 40 leader
colonoscopists to take account of compliance with the study.
For the primary endpoint, we used a generalised linear mixed
effects model with random colonoscopists and colonoscopists’
speciﬁc study phase effects, and ﬁxed effects for the study
group, phase, study group by phase interaction, and patient age
and sex.25 A generalised linear mixed effects model allows ana-
lysing changes in colonoscopists’ performance over time treating
them as a random sample from wider population and incorpor-
ating the possible correlation among outputs of participants
examined by the same colonoscopists. The model allowed
expressing the change in ADR at the participant level using ORs
with corresponding 95% CIs. The OR for the interaction term
reﬂects an excess in the OR of adenoma detection during the
postintervention phases versus the preintervention phase in the
TCL compared with the feedback group. Similar models were
ﬁtted for the secondary endpoints, including all the analyses
comparing late postintervention phase and preintervention
phase. Continuous variables (withdrawal technique scores, with-
drawal time and patient pain scores) were checked for normality
and compared using appropriate parametric or non-parametric
tests. A p value of <0.05 was considered statistically signiﬁcant.
All reported p values are two-sided and not adjusted for mul-
tiple testing. The analyses were performed using Stata Statistical
Software V.12 (Stata Corporation, College Station, Texas, USA).
RESULTS
Of the 40 screening centre leaders enrolled and randomised in a
1:1 ratio, one in each group was excluded due to consent with-
drawal or lack of participation in the NCRCSP in 2012.
Furthermore, in 2013, one screening centre leader in each
group left the centre. Thus, all analyses comparing early postin-
tervention phase and preintervention phase include 38 endosco-
pist leaders and their centres, whereas analyses comparing late
postintervention phase and preintervention phase include 36
endoscopist leaders and 38 centres (ﬁgure 1). Data analyses are
based on 24 582 colonoscopies performed by endoscopist
leaders (10 983 in the preintervention, 6358 in the early postin-
tervention, and 7241 in the late postintervention phase, respect-
ively) and 56 617 colonoscopies performed in total at the
participating centres throughout the trial phases (24 519 in the
preintervention, 14 654 in the early postintervention and
17 454 in the late postintervention phase).
The intervention groups were well balanced with regard to
baseline characteristics, colonoscopy experience and colonos-
copy trainer experience (table 1). Screening centre leaders from
both groups represented various medical specialties and types of
practices, including academic, non-academic and private.
Screening centre leaders’ performance
The characteristics of the screenees and colonoscopy procedures
by randomisation group and study phase are summarised in
table 2.
Early postintervention phase versus preintervention phase
As shown in ﬁgure 2, in the early postintervention phase, the
mean ADR of screening centre leaders in the TCL group
improved by 8.2% (from 17.4% to 25.6%) compared with
1.1% (from 18.5% to 19.6%) in the feedback groups, (absolute
difference 7.1%). The mean proximal ADR and non-polypoid
lesion detection rate of screening centre leaders in the TCL
group improved by 5.5% and 3.0%, respectively, whereas they
improved by 1.6% and deteriorated by 0.5% in the feedback
group, respectively (table 2). In the generalised linear mixed
effects models, participation in the TCL course was associated
with signiﬁcant ADR improvement (OR 1.61; 95% CI 1.29 to
2.01; p<0.001), proximal ADR improvement (OR 1.58; 95%
CI 1.19 to 2.11; p<0.001) and non-polypoid lesion detection
rate improvement (OR 2.78; 95% CI 1.53 to 5.05; p=0.001)
as compared with the feedback group. The mean CIR of screen-
ing centre leaders did not differ between the groups (OR 1.03;
95% CI 0.56 to 1.90; p=0.92). The changes in the mean ADR
were observed across all endoscopist specialties and types of
screening facilities (see online supplementary table S3 and sup-
plementary table S4 for the results of expanded model).
The changes in the above mentioned different detection rates
were in line with results of the assessments by endoscopy nurses
of 18 leaders in the TCL group (one centre leader was not
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assessed by nurses). Mean colonoscopy withdrawal technique
signiﬁcantly improved from 63.5 (±9.8) points to 68.2 (±7.8)
points (p=0.004), whereas mean colonoscopy withdrawal time
and mean pain scores remained unchanged (12.1±6.7 min to
12.5±9.0 min; p=0.54, and 18.4±17.2 mm to 12.8±10.8 mm;
p=0.16, respectively).
Late postintervention phase versus preintervention phase
As shown in ﬁgure 2, in the late postintervention phase the
mean ADR of screening centre leaders in the TCL group dete-
riorated by 1.7% compared with early postintervention phase,
but still remained improved by 6.5% compared with preinter-
vention phase. In the feedback group, the mean ADR of screen-
ing centre leaders in the late postintervention phase improved
by 1.2% compared with early postintervention phase and in
total by 2.3% compared with preintervention phase. The abso-
lute difference in the mean ADR improvement in the late post-
intervention phase compared with preintervention phase was
4.2% in favour of the TCL group. Results for proximal ADR
and non-polypoid lesion detection rate in the late postinterven-
tion phase are shown in ﬁgure 2 and table 2.
In the generalised linear mixed effects models, participation
in the TCL course was associated with sustained signiﬁcant
ADR improvement (OR 1.35; 95% CI 1.10 to 1.66; p=0.004)
compared with the feedback group. The proximal ADR
improvement (OR 1.33; 95% CI 0.98 to 1.80; p=0.07) and
non-polypoid lesion detection rate improvement (OR 1.57;
95% CI 0.76 to 3.24; p=0.219) were no longer statistically sig-
niﬁcantly higher compared with the feedback group.
Screening centre performance
The characteristics of the screenees and colonoscopy procedures
by randomisation group and study phase are summarised in
table 3.
Early postintervention phase versus preintervention phase
The non-polypoid lesion detection rate improved by 1.5%
(from 1.6% to 3.1%) and 0.2% (from 1.6% to 1.8%) in the
TCL and feedback screening centres, respectively (for changes
Figure 1 Study ﬂowchart. *One
screening centre leader did not
participate in the nurse assessment.
Table 1 Baseline characteristics of 38 screening centre leaders
and their colonoscopy and trainer experience in Train-Colonoscopy-
Leader (TCL) and feedback groups, respectively
TCL group, N=19 Feedback group, N=19
Baseline characteristics
Mean age (±SD) 48.5 (4.5) 48.8 (6.0)
Male sex—n (%) 15 (78.9) 17 (89.5)
Specialty—n (%)
Gastroenterology 10 (52.6) 14 (73.7)
General/oncological surgery 8 (42.1) 5 (26.3)
Other 1 (5.3) 0 (0.0)
Type of screening centre—n (%)
Academic 2 (10.5) 1 (5.3)
Non-academic 7 (36.8) 9 (47.4)
Private practice 10 (52.6) 9 (47.4)
Colonoscopy experience*
Years, mean (±SD) 15.1 (5.4) 15.2 (6.0)
Estimated number of colonoscopies performed—n (%)
1000–4999 4 (21.1) 2 (10.5)
5000–9999 8 (42.1) 9 (47.4)
10 000 or more 7 (36.8) 7 (36.8)
Interested to undergo additional training—n (%)
Yes 11 (57.9) 13 (68.4)
No 2 (10.5) 4 (21.1)
Not sure/not reported 6 (31.6) 2 (10.5)
Previous experience as a colonoscopy trainer—n (%)
Yes 13 (68.4) 12 (63.2)
No 5 (26.3) 5 (26.3)
Not sure/not reported 1 (5.3) 2 (10.5)
Because of rounding, percentages may not total 100.
*Data not available for one leader from the feedback group.
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in other quality indicators, see table 3). In the generalised linear
mixed effects models, participation of the leader endoscopist in
the TCL course was associated with signiﬁcant overall non-
polypoid lesion detection rate improvement in the screening
centre (OR 1.85; 95% CI 1.19 to 2.86; p=0.006), but not with
ADR (OR 1.11; 95% CI 0.93 to 1.34; p=0.25) or proximal
ADR (OR 1.17; 95% CI 0.91 to 1.50; p=0.21), or CIR (OR
0.86; 95% CI 0.58 to 1.29; p=0.47).
Late postintervention phase versus preintervention phase
As shown in ﬁgure 2, in the late postintervention phase, the
mean ADR, proximal ADR and non-polypoid lesion detection
rate of entire screening centres improved by 5.7%, 3.9% and
2.5%, respectively, in the TCL group as compared with 1.8%,
1.8% and 0.6%, in the feedback group, respectively.
In the generalised linear mixed effects models, participation
in the TCL course was associated with signiﬁcant ADR improve-
ment (OR 1.25; 95% CI 1.04 to 1.50; p=0.017) and non-
polypoid lesion detection rate improvement (OR 1.76; 95% CI
1.11 to 2.82; p=0.017) but not signiﬁcant proximal ADR
improvement (OR 1.23; 95% CI 0.97 to 1.55; p=0.082), as
compared with the feedback group.
Brief telephone survey among screening centre leaders
revealed that in the postintervention phase, 12 of them (63.2%)
have already delivered the training in their centres, and the rest
either had no candidates for training (15.8%), or plan to deliver
training in the future (15.8%), or left the centre (5.3%). The
mean ADR improved by 7.6% (from 18.2% to 25.8%) in the
centres where training had been already delivered and by 3.1%
(from 18.7% to 21.8%) in the remaining centres.
DISCUSSION
This is the ﬁrst multicentre randomised comparative trial which
shows that a dedicated Train-Colonoscopy-Leaders course
improves important quality indicators in colonoscopy. The train-
ing of screening centre leaders in teaching high quality colonos-
copy resulted in sustained change of their own practice and the
performance of the centre as a whole.
Our training course represents a novel concept, aiming at
multifaceted change in endoscopists’ skills and behaviours. The
training was targeted at screening centre leaders with the aim of
ensuring they appreciated the importance of high standards and
providing them with a variety of techniques to train their teams
on how to meet these standards. The training did focus on
teaching high quality colonoscopy, withdrawal technique and
non-polypoid lesion recognition, and on barriers for improve-
ments in ADR at individual centres including aspects of organ-
isation, workforce, communication, training and quality control.
Our training course used techniques drawn from skills improve-
ment, training the trainer and leadership courses developed in
the UK. This methodology is based on key principles of adult
learning and changing professional practice.24
Our primary study focus was leader’s performance. We
demonstrated that the TCL course resulted in a signiﬁcant and
sustained leader’s ADR improvement; thereby, we conﬁrmed
that one of the best ways to learn is by teaching.26
The robust design of our study allowed us also to investigate
the effect of training at the screening centre level. Indeed, in the
late postintervention phase, we observed signiﬁcant improve-
ment in the ADR and non-polypoid lesion detection rate at the
screening centre level. It was unrealistic to expect this to be
evident in the early postintervention phase as it takes time to
deliver the training to other endoscopists in screening centres.
Our large-scale nationwide study results extend those of a
recent single centre study showing ADR improvement with a
short educational intervention.19
Proximal colorectal adenomas and non-polypoid lesions may
play an important role in the development of interval
Table 2 Screenee and procedure characteristics and colonoscopy performance by randomisation group (Train-Colonoscopy-Leader (TCL) and
feedback groups) and study phase (procedures performed by screening centre leaders)
The TCL group (19 endoscopists)* The feedback group (19 endoscopists)*
Preintervention
phase, N=6217
Early
postintervention
phase, N=3381
Late
postintervention
phase, N=3826
Preintervention
phase, N=4766
Early
postintervention
phase, N=2977
Late
postintervention
phase, N=3415
Screenee variables
Age, mean (±SD) 56.4 (5.4) 56.9 (5.4) 56.9 (5.4) 56.7 (5.2) 57.0 (5.3) 57.1 (5.1)
Male sex—n (%) 2237 (36.0) 1175 (34.7) 1525 (39.9) 1783 (37.4) 1123 (37.7) 1385 (40.7)
Procedure variables
Intravenous sedation—n (%) 4000 (64.3%) 2011 (59.5%) 2330 (60.9%) 2644 (55.5%) 1628 (54.7%) 1877 (55.0)
Adequate bowel preparation†—n (%) 5833 (93.8%) 3240 (95.8%) 3610 (94.4%) 4520 (94.8%) 2724 (91.5%) 3185 (93.3%)
Total colonoscopy—n (%) 5995 (96.4%) 3268 (96.7%) 3690 (96.4%) 4631 (97.2%) 2870 (96.4%) 3322 (97.3%)
Screenees with adenoma or cancer—n (%) 1023 (16.4%) 812 (24.0%) 897 (23.4%) 898 (18.8%) 574 (19.3%) 719 (21.1%)
Screenees with polyps not removed/retrieved—n (%) 31 (0.5%) 20 (0.6%) 14 (0.4%) 26 (0.5%) 18 (0.6%) 25 (0.7%)
Screenees with proximal‡ adenoma or cancer—n (%) 430 (6.9%) 421 (12.4%) 452 (11.8%) 426 (8.9%) 312 (10.5%) 389 (11.4%)
Screenees with non-polypoid lesion§—n (%) 112 (1.8%) 128 (3.8%) 143 (3.7%) 79 (1.7%) 45 (1.5%) 84 (2.5%)
Screening centre leader performance variables
Number of colonoscopies, median (range) 258 (40–898) 182 (21–443) 187 (20–519) 187 (120–384) 88 (57–296) 124 (34–514)
Adenoma detection rate, mean (±SD) 17.4% (3.2) 25.6% (8.2) 23.9% (4.7) 18.5% (3.6) 19.6% (6.5) 20.8% (6.1)
Proximal‡ adenoma detection rate, mean (±SD) 7.8% (2.6) 13.3% (6.1) 12.0% (4.9) 8.6% (3.7) 10.2% (4.9) 10.2% (4.9)
Non-polypoid lesion§ detection rate, mean (±SD) 1.8% (1.9) 4.8% (4.5) 3.8% (4.0) 2.0% (2.0) 1.5% (1.3) 2.1% (2.2)
Caecal intubation rate, mean (±SD) 96.5% (4.2) 95.8% (4.4) 96.3% (4.5) 96.5% (2.7) 95.2% (4.6) 96.2% (4.1)
*In the late postintervention phase, one leader in each group left the screening centre; the remaining 36 endoscopists were used for analyses.
†Bowel preparation was assessed by endoscopists.
‡Proximal to the splenic flexure.
§Non-polypoid lesion was defined as a lesion 5 mm or larger which was depressed, completely flat or elevated less than 2.5 mm.
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CRCs.27 28 Our study is the ﬁrst to demonstrate signiﬁcant
improvement in proximal ADR and non-polypoid lesion detec-
tion rate following quality improvement intervention. These
results are in line with the primary goals of the training curricu-
lum: emphasis on detection of subtle, non-polypoid lesions and
visualisation of the proximal colon.
Endoscopist specialty and type of facility in which colonos-
copy was performed have been associated with the risk of inter-
val CRC.29 In our study, ADR improvement was observed
across all endoscopist specialties, colonoscopy experience and
types of screening facilities (see online supplementary table S3).
In contrast, in previous studies on quality improvement through
educational intervention, only gastroenterologists from academic
institutions were included.13 19
The underlying hypothesis of our educational interventions
was that the improvement in the detection of adenomas trans-
lates into reduced interval CRC rates. A recent large-scale study
suggests that each 1% increase in ADR may result in a 3%
decrease in the risk of interval cancer.3 We intend to follow our
study cohort to investigate if improvement in ADR translates
into reduced interval CRC rates.
Our study has some limitations. First, the cost-effectiveness of
the training intervention is unknown. However, assuming that
the relative risk of interval CRC among endoscopists with high
and low ADR is comparable or greater than that observed for
gastroenterologist and non-gastroenterologist endoscopists,29 30
it is likely that training to improve ADR will be as cost-effective
as shifting screening colonoscopies from non-gastroenterologist
endoscopists to gastroenterologist endoscopists.31 Second, total
colonoscopy and withdrawal time were not routinely measured
in our study. Thus, impact of the study interventions on proced-
ure times is unknown. However, short term assessments, done
by endoscopy nurses before and after intervention, suggest that
observed improvement in ADR in the TCL group was most
likely due to improved withdrawal technique rather than longer
withdrawal time. This observation is in line with results of a pre-
vious study which showed that compared with withdrawal time,
withdrawal technique might better differentiate between endos-
copists with varying ADRs.32 Third, continuous, more frequent
feedback of colonoscopy quality might be more effective than
annual feedback. We decided to give feedback annually because
of the sample size required to give a sufﬁciently precise estimate
of ADR.33 Fourth, screening centre leaders were aware of being
monitored under the study conditions. This might have affected
their postintervention colonoscopy performance (the so-called
Hawthorne effect34). Indeed, it is likely that some Hawthorne
Figure 2 Mean (with 95% CIs)
adenoma detection rate (ADR),
proximal adenoma detection rate
(pADR) and non-polypoid lesion
detection rate (ﬂatPDR) in the
preintervention phase (2011), early
postintervention phase (2012) and late
postintervention phase (2013) by study
group. Panel A shows data for
screening centre leaders. Panel B
shows data for entire screening
centres. TCL, Train-Colonoscopy-Leader
group; Feedback, feedback group.
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Table 3 Screenee and procedure characteristics and colonoscopy performance by randomisation group and study phase (procedures performed by all endoscopists at the study centres)
Variables
The TCL group (70 endoscopists, 19 centres) The feedback group (68 endoscopists, 19 centres)
Preintervention phase,
N=14 264
Early postintervention
phase, N=8657
Late postintervention
phase, N=10 615
Preintervention phase,
N=10 255
Early postintervention
phase, N=5987
Late postintervention
phase, N=6839
Screenee variables
Age, mean (±SD) 56.3 (5.6) 56.4 (5.8) 56.5 (5.8) 56.7 (5.2) 57.0 (5.4) 57.1 (5.2)
Male sex—n (%) 5414 (38.0) 3242 (37.4) 4360 (41.1%) 3853 (37.6) 2239 (37.4) 2786 (40.7%)
Procedure variables
Intravenous sedation—n (%) 7944 (55.7%) 4395 (50.8%) 4986 (47.0%) 5037 (49.1%) 2848 (47.6%) 3342 (48.9%)
Adequate bowel preparation*—n (%) 13 495 (94.6%) 8302 (95.9%) 10 185 (95.9%) 9635 (94.0%) 5519 (92.9%) 6441 (94.2%)
Total colonoscopy—n (%) 13 776 (96.6%) 8366 (96.6%) 10 269 (96.7%) 9839 (95.9%) 5747 (96.0%) 6631 (97.0%)
Screenees with adenoma or cancer—n (%) 2621 (18.4%) 1996 (23.1%) 2495 (23.5%) 1938 (18.9%) 1279 (21.4%) 1407 (20.6%)
Screenees with polyps not removed/retrieved—n (%) 73 (0.5%) 49 (0.6%) 41 (0.4%) 52 (0.5%) 31 (0.5%) 50 (0.7%)
Screenees with proximal† adenoma or cancer—n (%) 1204 (8.4%) 1037 (12.0%) 1280 (12.1%) 929 (9.1%) 647 (10.8%) 739 (10.8%)
Screenees with non-polypoid‡ lesion—n (%) 230 (1.6%) 270 (3.1%) 399 (3.8%) 161 (1.6%) 109 (1.8%) 142 (2.1%)
Entire screening centre performance variables
No. of endoscopists per centre
Mean (±SD) 3.7 (2.7) 3.7 (2.6) 3.7 (2.6) 3.5 (1.6) 3.6 (1.7) 3.6 (1.5)
Median (range) 3 (1–13) 3 (1–12) 3 (1–13) 4 (1–7) 4 (1–7) 4 (1–7)
Number of colonoscopies, median (range) 633 (147–2357) 336 (74–1787) 380 (150–2400) 539 (198–1097) 300 (106–670) 336 (204–600)
Adenoma detection rate, mean (±SD) 18.4% (2.9) 22.9% (4.7) 24.1% (5.6) 18.5% (3.6) 21.6% (5.1) 20.3% (5.1)
Proximal† adenoma detection rate, mean (±SD) 8.6% (2.5) 12.0% (4.0) 12.5% (4.3) 9.0% (3.2) 11.0% (4.0) 10.8% (3.9)
Non-polypoid lesion‡ detection rate, mean (±SD) 1.6% (1.3) 3.6% (3.4) 4.1 (2.8) 1.5% (1.3) 1.7% (1.1) 2.1 (1.7)
Caecal intubation rate, mean (±SD) 96.3% (3.2) 96.6% (2.4) 96.5% (2.7) 95.6% (2.5) 95.8% (3.3) 95.9% (3.4)
*Bowel preparation was assessed by endoscopists.
†Proximal to the splenic flexure.
‡Non-polypoid lesion was defined as a lesion 5 mm or larger which was depressed, completely flat or elevated less than 2.5 mm.
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effect occurred in our study because in the late postintervention
phase, colonoscopy performance of screening centre leaders
declined slightly compared with the early postintervention
phase. However, a Hawthorne effect had likely relatively small
impact on our study results. Furthermore, this study included
screening centre leaders with ADRs below 25%. It is uncertain
if our results are applicable to leaders of endoscopy units
outside screening setting and endoscopists with ADRs higher
than 25%. Fifth, two screening centre leaders in each study
group were lost to follow-up in the late postintervention phase,
and thus the analyses for this period were not purely on an
intention to treat basis. However, in the analyses we included all
the data from screenees who underwent examination by endos-
copists who performed screening examinations in the postinter-
vention phase and did not withdraw their consent to participate
in the trial, regardless of whether the training was complete or
not (one screening centre leader did not participate in the pre-
training and the post-training assessment but was included in
the analyses). Moreover, in the late postintervention phase, we
analysed all the centres that continued the screening pro-
gramme, despite two leaders leaving their centres.
In summary, participation in a short, dedicated training inter-
vention for screening centre leaders resulted in a greater
improvement in ADR than audit and feedback of individual col-
onoscopy quality indicators. The observed quality improvement
among leading colonoscopists and its dissemination on the
entire screening centres support its widespread implementation.
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